Mouse Anti-GMPPB Recombinant Antibody (CBLG1-147) (CBMAB-G0561-LY)

Name: Mouse Anti-GMPPB Recombinant Antibody (CBLG1-147)
SKU: CBMAB-G0561-LY
Rating: 5 (1 reviews)

See all GMPPB antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBLG1-147

Application

ELISA, WB, IHC-P

Immunogen

GMPPB (aa 1-110) partial recombinant protein.

Specificity

Human, Mouse, Rat

Antibody Isotype

IgG2b, κ

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

PBS

Preservative

None

Concentration

Batch dependent

Purity

> 95% Purity determined by SDS-PAGE.

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

More Infomation

Target

Full Name

GDP-mannose pyrophosphorylase B

Introduction

This gene is thought to encode a GDP-mannose pyrophosphorylase. The encoded protein catalyzes the conversion of mannose-1-phosphate and GTP to GDP-mannose, a reaction involved in the production of N-linked oligosaccharides. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jan 2009]

Entrez Gene ID

29925

UniProt ID

Q9Y5P6

Alternative Names

GDP-Mannose Pyrophosphorylase B; GTP-Mannose-1-Phosphate Guanylyltransferase Beta; Mannose-1-Phosphate Guanyltransferase Beta; EC 2.7.7.13; MDDGA14; MDDGB14; MDDGC14;

Function

Catalyzes the formation of GDP-mannose, an essential precursor of glycan moieties of glycoproteins and glycolipids.

Biological Process

GDP-mannose biosynthetic process Source: UniProtKB

Cellular Location

Cytoplasm

Involvement in disease

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14 (MDDGA14):
An autosomal recessive disorder characterized by congenital muscular dystrophy associated with brain anomalies, eye malformations, and profound mental retardation. The disorder includes a severe form designated as Walker-Warburg syndrome and a less severe phenotype known as muscle-eye-brain disease. MDDGA14 features include increased muscle tone, microcephaly, cleft palate, feeding difficulties, severe muscle weakness, sensorineural hearing loss, cerebellar hypoplasia, ataxia, and retinal dysfunction.
Muscular dystrophy-dystroglycanopathy congenital with mental retardation B14 (MDDGB14):
A congenital muscular dystrophy characterized by severe muscle weakness apparent in infancy and mental retardation. Some patients may have additional features, such as microcephaly, cardiac dysfunction, seizures, or cerebellar hypoplasia.
Muscular dystrophy-dystroglycanopathy limb-girdle C14 (MDDGC14):
An autosomal recessive form of muscular dystrophy characterized by mild proximal muscle weakness with onset in early childhood. Some patients may have additional features, such as mild intellectual disability or seizures.

Chompoopong, P., & Milone, M. (2023). GDP-Mannose Pyrophosphorylase B (GMPPB)-Related Disorders. Genes, 14(2), 372.

Polavarapu, K., Mathur, A., Joshi, A., Nashi, S., Preethish-Kumar, V., Bardhan, M., ... & Faruq, M. (2021). A founder mutation in the GMPPB gene [c. 1000G> A (p. Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients. neurogenetics, 22, 271-285.

Zheng, L., Liu, Z., Wang, Y., Yang, F., Wang, J., Huang, W., ... & Jia, D. (2021). Cryo-EM structures of human GMPPA–GMPPB complex reveal how cells maintain GDP-mannose homeostasis. Nature Structural & Molecular Biology, 28(5), 1-12.

Liu, Z., Wang, Y., Yang, F., Yang, Q., Mo, X., Burstein, E., ... & Tu, Y. (2021). GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB. Molecular Biomedicine, 2, 1-11.

Sun, L., Shen, D., Xiong, T., Zhou, Z., Lu, X., & Cui, F. (2020). Limb-girdle muscular dystrophy due to GMPPB mutations: A case report and comprehensive literature review. Bosnian Journal of Basic Medical Sciences, 20(2), 275.

Tian, W. T., Zhou, H. Y., Zhan, F. X., Zhu, Z. Y., Yang, J., Chen, S. D., ... & Cao, L. (2019). Lysosomal degradation of GMPPB is associated with limb‐girdle muscular dystrophy type 2T. Annals of Clinical and Translational Neurology, 6(6), 1062-1071.

Nicolau, S., Liewluck, T., Shen, X. M., Selcen, D., Engel, A. G., & Milone, M. (2019). A homozygous mutation in GMPPB leads to centronuclear myopathy with combined pre-and postsynaptic defects of neuromuscular transmission. Neuromuscular Disorders, 29(8), 614-617.

Sarkozy, A., Torelli, S., Mein, R., Henderson, M., Phadke, R., Feng, L., ... & Muntoni, F. (2018). Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy. Journal of Neurology, Neurosurgery & Psychiatry, 89(7), 762-768.

Astrea, G., Romano, A., Angelini, C., Antozzi, C. G., Barresi, R., Battini, R., ... & Santorelli, F. M. (2018). Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. Orphanet journal of rare diseases, 13(1), 1-9.

Panicucci, C., Fiorillo, C., Moro, F., Astrea, G., Brisca, G., Trucco, F., ... & Bruno, C. (2018). Mutations in GMPPB presenting with pseudometabolic myopathy. JIMD Reports, Volume 38, 23-31.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-GMPPB Recombinant Antibody (CBLG1-147)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry